Literature DB >> 15767406

Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts.

Guido Silvestri1, Andrew Fedanov, Stephanie Germon, Natalia Kozyr, William J Kaiser, David A Garber, Harold McClure, Mark B Feinberg, Silvija I Staprans.   

Abstract

To understand how natural sooty mangabey hosts avoid AIDS despite high levels of simian immunodeficiency virus (SIV) SIVsm replication, we inoculated mangabeys and nonnatural rhesus macaque hosts with an identical inoculum of uncloned SIVsm. The unpassaged virus established infection with high-level viral replication in both macaques and mangabeys. A species-specific, divergent immune response to SIV was evident from the first days of infection and maintained in the chronic phase, with macaques showing immediate and persistent T-cell proliferation, whereas mangabeys displayed little T-cell proliferation, suggesting subdued cellular immune responses to SIV. Importantly, only macaques developed (CD4+)-T-cell depletion and AIDS, thus indicating that in mangabeys limited immune activation is a key mechanism to avoid immunodeficiency despite high levels of SIVsm replication. These studies demonstrate that it is the host response to infection, rather than properties inherent to the virus itself, that causes immunodeficiency in SIV-infected nonhuman primates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767406      PMCID: PMC1061583          DOI: 10.1128/JVI.79.7.4043-4054.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection.

Authors:  M A Nowak; A L Lloyd; G M Vasquez; T A Wiltrout; L M Wahl; N Bischofberger; J Williams; A Kinter; A S Fauci; V M Hirsch; J D Lifson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Getting to the HAART of T cell dynamics.

Authors:  M Roederer
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

3.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

4.  Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.

Authors:  M T Roos; R A van Lier; D Hamann; G J Knol; I Verhoofstad; D van Baarle; F Miedema; P T Schellekens
Journal:  J Infect Dis       Date:  2000-07-24       Impact factor: 5.226

5.  Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.

Authors:  A Watson; J Ranchalis; B Travis; J McClure; W Sutton; P R Johnson; S L Hu; N L Haigwood
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop.

Authors:  Z Chen; P Telfier; A Gettie; P Reed; L Zhang; D D Ho; P A Marx
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

8.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

9.  Experimental leprosy in monkeys. II. Longitudinal serological observations in sooty mangabey monkeys.

Authors:  B J Gormus; K Xu; S N Cho; G B Baskin; R P Bohm; L N Martin; J L Blanchard; P A Mack; M S Ratterree; W M Meyers
Journal:  Lepr Rev       Date:  1995-06       Impact factor: 0.537

10.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  103 in total

1.  Immunovirological analyses of chronically simian immunodeficiency virus SIVmnd-1- and SIVmnd-2-infected mandrills (Mandrillus sphinx).

Authors:  Cristian Apetrei; Beth Sumpter; Sandrine Souquiere; Ann Chahroudi; Maria Makuwa; Patricia Reed; Ruy M Ribeiro; Ivona Pandrea; Pierre Roques; Guido Silvestri
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

3.  A five-year longitudinal analysis of sooty mangabeys naturally infected with simian immunodeficiency virus reveals a slow but progressive decline in CD4+ T-cell count whose magnitude is not predicted by viral load or immune activation.

Authors:  Jessica Taaffe; Ann Chahroudi; Jessica Engram; Beth Sumpter; Tracy Meeker; Sarah Ratcliffe; Mirko Paiardini; James Else; Guido Silvestri
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

4.  Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites.

Authors:  Ivona Pandrea; Nicholas F Parrish; Kevin Raehtz; Thaidra Gaufin; Hannah J Barbian; Dongzhu Ma; Jan Kristoff; Rajeev Gautam; Fang Zhong; George S Haret-Richter; Anita Trichel; George M Shaw; Beatrice H Hahn; Cristian Apetrei
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

5.  Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys.

Authors:  M Paiardini; B Cervasi; B Sumpter; H M McClure; D L Sodora; M Magnani; S I Staprans; G Piedimonte; G Silvestri
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Authors:  Mireille Laforge; Ricardo Silvestre; Vasco Rodrigues; Julie Garibal; Laure Campillo-Gimenez; Shahul Mouhamad; Valérie Monceaux; Marie-Christine Cumont; Henintsoa Rabezanahary; Alain Pruvost; Anabela Cordeiro-da-Silva; Bruno Hurtrel; Guido Silvestri; Anna Senik; Jérôme Estaquier
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

7.  Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques.

Authors:  Jacob D Estes; Shari N Gordon; Ming Zeng; Ann M Chahroudi; Richard M Dunham; Silvija I Staprans; Cavan S Reilly; Guido Silvestri; Ashley T Haase
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

8.  The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.

Authors:  Frederic Bibollet-Ruche; Brett A McKinney; Alexandra Duverger; Frederic H Wagner; Aftab A Ansari; Olaf Kutsch
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys.

Authors:  Steven E Bosinger; Qingsheng Li; Shari N Gordon; Nichole R Klatt; Lijie Duan; Luoling Xu; Nicholas Francella; Abubaker Sidahmed; Anthony J Smith; Elizabeth M Cramer; Ming Zeng; David Masopust; John V Carlis; Longsi Ran; Thomas H Vanderford; Mirko Paiardini; R Benjamin Isett; Don A Baldwin; James G Else; Silvija I Staprans; Guido Silvestri; Ashley T Haase; David J Kelvin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

Review 10.  Resolution of immune activation defines nonpathogenic SIV infection.

Authors:  Olivier Manches; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.